BRIEF — Beijing Luzhu Biotechnology Says Recombinant RSV Vaccine Approved For Clinical Trials In China
Oct 12 (Reuters) — Beijing Luzhu Biotechnology Co Ltd: Recombinant Rsv Vaccine Approved For Clinical Trials In China Further company coverage: 2480.HK (Reuters.Briefs@thomsonreuters.com;)